Nasdaq vktx.

Viking Therapeutics, Inc. (NASDAQ:VKTX) is up about 315% over the past one year. Viking Therapeutics, Inc. (NASDAQ:VKTX) in July filed for a mixed securities shelf offering.Dec 4, 2023 · Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have received an average rating of “Buy” from the nine analysts that are presently covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy recommendation. The average 12 month target price among brokers that have covered the stock in the […] צפה בגרף ‎Viking Therapeutics, Inc.‎ בזמן אמת כדי לעקוב אחר תנועת מחיר המניה. תמצא תחזיות שוק, ‎VKTX‎ וחדשות שוק כלכליות.Financial News. View the latest Viking Therapeutics Inc. (VKTX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Since the year began, shares of Viking Therapeutics (NASDAQ:VKTX) exploded from about $8 to about $25 a share. All thanks to its potential treatment for obesity, VK2735.In the last 3 months, 9 analysts have offered 12-month price targets for Viking Therapeutics. The company has an average price target of $33.0 with a high of $40.00 and a low of $24.00. Below is a ...

Viking Therapeutics, Inc. Common Stock (VKTX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Viking Therapeutics Inc (NASDAQ:VKTX) Viking Therapeutics Inc. 13.01. Delayed Data. As of Dec 01. +0.79 / +6.42%. Today’s Change. 3.54. Today ||| 52-Week Range.

VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The …Viking Therapeutics (NASDAQ:VKTX) Lifted to Sell at StockNews.com marketbeat.com - August 24 at 1:17 AM: 5 Best Weight Loss Stocks To Invest In insidermonkey.com - August 22 at 5:54 PM: E Fund Management Co. Ltd. Invests $511,000 in Viking Therapeutics, Inc. (NASDAQ:VKTX) marketbeat.com - August 22 at 9:24 AMNasdaq Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology platform allows you to search, discover and access ...Fintel reports that on July 27, 2023, HC Wainwright & Co. reiterated coverage of Viking Therapeutics (NASDAQ:VKTX) with a Buy recommendation. Analyst Price Forecast Suggests 141.43% Upside. As of ...

SAN DIEGO, Feb. 17, 2021 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ...

SAN DIEGO, Nov. 2, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will participate at several upcoming investor conferences.

The latest price target for . Viking Therapeutics (NASDAQ: VKTX) was reported by Truist Securities on Monday, October 2, 2023.The analyst firm set a price target for 32.00 expecting VKTX to rise ...Below is Validea's guru fundamental report for VIKING THERAPEUTICS INC (VKTX). Of the 22 guru strategies we follow, VKTX rates highest using our Quantitative Momentum Investor model based on the ...So we'll take a look at whether insiders have been buying or selling shares in Viking Therapeutics, Inc. (NASDAQ:VKTX). ... NasdaqCM:VKTX Insider Trading Volume May 13th 2021.EPS Estimate Trends. Current. N/A. 1 Month Ago. -$0.24. 3 Months Ago. -$0.24. Viking Therapeutics Inc. analyst estimates, including VKTX earnings per share estimates and analyst recommendations.Shares of Viking Therapeutics ( VKTX 6.23%) were up 89.7% for the week as of Thursday afternoon, after being up as much as 95.5% for the week, according to data provided by S&P Global Market ...For Viking Therapeutics (NASDAQ: VKTX) that’s exactly what investors get. VKTX has currently five drugs in its development pipeline. Those drugs are targeting a variety of diseases including ...Turning to the calls side of the option chain, the call contract at the $18.00 strike price has a current bid of $1.05. If an investor was to purchase shares of VKTX stock at the current price ...

Research Viking Therapeutics' (Nasdaq:VKTX) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance ...See the latest Viking Therapeutics Inc stock price (VKTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.View real-time VKTX stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ...Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...About Latest Pre-Market Trades. Nasdaq provides market information opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. See Also. Nasdaq MarketSIte. Do Not Sell My Personal ...Viking Therapeutics, Inc. (NASDAQ: VKTX) is an American biotechnology company that is focused on the development of novel and orally available therapies for the treatment of metabolic and ...Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

Market Cap. $1.3B. Currency in USD. Quote data delayed by at least 15 minutes.Feb 9, 2023 · Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2022 Results Conference Call February 8, 2023 4:30 AM ETCompany Participants. Stephanie Diaz - Investor Relations. Brian Lian - President and Chief ...

View real-time VKTX stock price and news, along with industry-best analysis. ... Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet, Dow Jones. ETF Movers: Includes ETFs & ETNs with ... Mar 29, 2023 · Shares of Viking Therapeutics VKTX have surged almost 70% on Mar 28, after it announced positive clinical data of VK2735, a novel dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose ... Viking Therapeutics said VK2809 met the main goal of a phase 2b trial by showing statistically significant reductions in liver fat in patients with NASH. VKTX +12% yesterday, @CR144 Research ...The three major U.S. stock exchanges are the New York Stock Exchange (NYSE), the NASDAQ and the American Stock Exchange (AMEX). As of 2014, the NYSE is the largest and most prestigious of the three. The NASDAQ is a virtual stock exchange.SAN DIEGO, April 11, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for ...Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the presentation of new results from the ongoing Phase 2b clinical trial of VK2809, the company's novel liver-selective thyroid hormone receptor …VKTX U.S.: Nasdaq Viking Therapeutics Inc. Watch NEW Set a price target alert After Hours Last Updated: Dec 1, 2023 7:47 p.m. EST Delayed quote $ 13.10 0.09 0.69% After …Viking Therapeutics Inc ( NASDAQ:VKTX) reported a strong quarter-end cash position of $376M. The company's net loss for Q3 2023 was $22.5 million, or $0.23 per share, compared to a net loss of $15 ...

VFS. VinFast Auto Ltd. Ordinary Shares. $17.15 -0.84 -4.67%. Find the latest news headlines from Viking Therapeutics, Inc. Common Stock (VKTX) at Nasdaq.com.

The largest stake in Viking Therapeutics, Inc. (NASDAQ:VKTX) was held by Park West Asset Management, which reported holding $7.5 million worth of stock at the end of September.It was followed by ...For Viking Therapeutics (NASDAQ: VKTX) that’s exactly what investors get. VKTX has currently five drugs in its development pipeline. Those drugs are targeting a variety of diseases including ...Today's Change. (1.85%) $0.21. Current Price. $11.56. Price as of November 22, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium ...Research Viking Therapeutics' (Nasdaq:VKTX) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance ...Feb 28, 2023 · 784,592. 4.713748. Back to VKTX Overview. NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end ... VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83.Viking Therapeutics Stock Price, News & Analysis (NASDAQ:VKTX) $13.01 +0.79 (+6.46%) (As of 12/1/2023 ET) Today's Range $11.82 $13.10 50-Day Range $9.24 …Dec 14, 2022 · Viking Therapeutics (NASDAQ:VKTX) is a great speculative biotech play to look into. The reason why I state that is because I believe it has huge potential as a long-term play. Viking Therapeutics Inc (NASDAQ:VKTX) shares are down by over 9% year to date bringing their 12-month return to over 142%. As of this writing, Viking Therapeutics shares are trading at around $8.60 with a 52-week range of $2.02 to $9.62, giving the company a market capitalization of more than $660 million. Summit Therapeutics (257%)Strong Quarter-End Cash Position of $376M. SAN DIEGO, Oct. 25, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the ...VKTX U.S.: Nasdaq Viking Therapeutics Inc. Watch NEW Set a price target alert After Hours Last Updated: Nov 20, 2023 7:59 p.m. EST Delayed quote $ 11.78 0.01 0.08% After Hours Volume: 20.04K...

Stock Activity Open 12.40 Day Low 11.82 Day High 13.10 52 Wk Low 3.54 52 Wk High 25.72 Avg. Volume 1,501,039 Market Cap 1.22 B Dividend 0.00 ( 0.00%) Beta …Viking Therapeutics Inc (NASDAQ: VKTX) shares are trading higher Tuesday after the company presented new data from its Phase 2b studyViking Therapeutics (NASDAQ: VKTX) is one of the more exciting biopharma stocks out there. The firm is developing novel therapies to address endocrine and metabolic disorders. It has more than ...SAN DIEGO, April 3, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ...Instagram:https://instagram. bezinga optionsdeep value stockslitptucker york goldman sachs Dec 15, 2019 · Of the funds tracked by Insider Monkey, Peter S. Park's Park West Asset Management has the largest position in Viking Therapeutics, Inc. (NASDAQ:VKTX), worth close to $12 million, accounting for 0 ... stamp price 2022best credit cards for groceries and dining Apr 24, 2023 · Fintel reports that on April 25, 2023, Oppenheimer maintained coverage of Viking Therapeutics (NASDAQ:VKTX) with a Outperform recommendation.. Analyst Price Forecast Suggests 29.59% Upside. As of ... evav stock VKTX has move up from $4.00 a share to nearly $11.00 a share, largely in sympathy since those Madrigal trial results were announced. Therefore, I have taken profits on most of my small stake in VKTX.Nov 2, 2023 · SAN DIEGO, Nov. 2, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic ... The "Mad Money" host said Viking Therapeutics, Inc. (NASDAQ:VKTX) is a "very good spec, but you have to understand it could be wiped out or go up a lot." Price Action: ...